ADC Therapeutics SA Adjustments For Amortisation Expense
ADC Therapeutics SA (ADCT) reported Adjustments For Amortisation Expense of $155.00 thousand for the 9-month period ending 2023-09-30, per its 6-K filed 2023-11-07.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:AdjustmentsForAmortisationExpense · last filed 2023-11-07
- ADC Therapeutics SA adjustments for amortisation expense for the quarter ending 2023-09-30 was $52.00K, a 67.74% increase year-over-year.
- ADC Therapeutics SA adjustments for amortisation expense for the quarter ending 2023-06-30 was $51.00K, a 64.52% increase year-over-year.
- ADC Therapeutics SA adjustments for amortisation expense for the quarter ending 2023-03-31 was $52.00K, a 100.00% increase year-over-year.
- ADC Therapeutics SA adjustments for amortisation expense for the quarter ending 2022-12-31 was $30.00K, a 9.09% decline year-over-year.
| Period end | Adjustments For Amortisation Expense 3 month | Adjustments For Amortisation Expense 6 month | Adjustments For Amortisation Expense 9 month | Adjustments For Amortisation Expense 12 month |
|---|---|---|---|---|
| 2023-09-30 | $52.00K derived: 6-K 9 month − 6-K 6 month · filed 2023-11-07 | $103.00K derived: sum of 2 quarters · filed 2023-11-07 | $155.00K 6-K · filed 2023-11-07 | $185.00K derived: sum of 4 quarters · filed 2023-11-07 |
| 2023-06-30 | $51.00K derived: 6-K 6 month − 6-K 3 month · filed 2023-08-08 | $103.00K 6-K · filed 2023-08-08 | $133.00K derived: sum of 3 quarters · filed 2023-08-08 | $164.00K derived: sum of 4 quarters · filed 2023-11-07 |
| 2023-03-31 | $52.00K 6-K · filed 2023-05-09 | $82.00K derived: sum of 2 quarters · filed 2023-05-09 | $113.00K derived: sum of 3 quarters · filed 2023-11-07 | $144.00K derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-12-31 | $30.00K derived: 20-F 12 month − 6-K 9 month · filed 2023-03-15 | $61.00K derived: sum of 2 quarters · filed 2023-11-07 | $92.00K derived: sum of 3 quarters · filed 2023-11-07 | $118.00K 20-F · filed 2023-03-15 |
| 2022-09-30 | $31.00K derived: 6-K 9 month − 6-K 6 month · filed 2023-11-07 | $62.00K derived: sum of 2 quarters · filed 2023-11-07 | $88.00K 6-K · filed 2023-11-07 | $121.00K derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $31.00K derived: 6-K 6 month − 6-K 3 month · filed 2023-08-08 | $57.00K 6-K · filed 2023-08-08 | $90.00K derived: sum of 3 quarters · filed 2023-08-08 | $123.00K derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $26.00K 6-K · filed 2023-05-09 | $59.00K derived: sum of 2 quarters · filed 2023-05-09 | $92.00K derived: sum of 3 quarters · filed 2023-05-09 | $130.00K derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $33.00K derived: 20-F 12 month − 6-K 9 month · filed 2023-03-15 | $66.00K derived: sum of 2 quarters · filed 2023-03-15 | $104.00K derived: sum of 3 quarters · filed 2023-03-15 | $129.00K 20-F · filed 2023-03-15 |
| 2021-09-30 | $33.00K derived: 6-K 9 month − 6-K 6 month · filed 2022-11-08 | $71.00K derived: sum of 2 quarters · filed 2022-11-08 | $96.00K 6-K · filed 2022-11-08 | $115.00K derived: sum of 4 quarters · filed 2023-03-15 |
| 2021-06-30 | $38.00K derived: 6-K 6 month − 6-K 3 month · filed 2022-08-09 | $63.00K 6-K · filed 2022-08-09 | $82.00K derived: sum of 3 quarters · filed 2023-03-15 | $93.00K derived: sum of 4 quarters · filed 2023-03-15 |
| 2021-03-31 | $25.00K 6-K · filed 2022-05-09 | $44.00K derived: sum of 2 quarters · filed 2023-03-15 | $55.00K derived: sum of 3 quarters · filed 2023-03-15 | $63.00K derived: sum of 4 quarters · filed 2023-03-15 |
| 2020-12-31 | $19.00K derived: 20-F 12 month − 6-K 9 month · filed 2023-03-15 | $30.00K derived: sum of 2 quarters · filed 2023-03-15 | $38.00K derived: sum of 3 quarters · filed 2023-03-15 | $47.00K 20-F · filed 2023-03-15 |
| 2020-09-30 | $11.00K derived: 6-K 9 month − 6-K 6 month · filed 2021-11-02 | $19.00K derived: sum of 2 quarters · filed 2021-11-02 | $28.00K 6-K · filed 2021-11-02 | |
| 2020-06-30 | $8.00K derived: 6-K 6 month − 6-K 3 month · filed 2021-08-03 | $17.00K 6-K · filed 2021-08-03 | ||
| 2020-03-31 | $9.00K 6-K · filed 2021-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |